(Q30816299)

English

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations (English)

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

multiple sclerosis

0 references

relapsing-remitting multiple sclerosis

0 references

methylprednisolone

1 reference

based on heuristic

inferred from title

Florian Holsboer

8

object named as

Florian Holsboer

0 references

Claudia Trenkwalder

13

object named as

Claudia Trenkwalder

0 references

10

object named as

Manfred Uhr

0 references

2

object named as

Tania Kümpfel

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

object named as

Ulrike Held

4

0 references

Dorothee P. Auer

object named as

Dorothee P Auer

14

0 references

Florian Then Bergh

1

object named as

Florian Then Bergh

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

author name string

Erina Schumann

3

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Michaela Schwan

5

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Mirjana Blazevic

6

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Axel Wismüller

7

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Alexander Yassouridis

9

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Frank Weber

11

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Martin Daumer

12

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

publication date

23 May 2006

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

6

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

19

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Dexamethasone and adrenocorticotropin suppress prolactin secretion in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

Neuroendocrine regulation of immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis. Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

Interferon beta treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

Early activation of thyrotropin-releasing-hormone and prolactin plays a critical role during a T cell-dependent immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

Hyperprolactinemia in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

The effect of high-dose steroids on MRI gadolinium enhancement in acute demyelinating lesions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

21 June 2018

Retained intraocular cilium in the presence of silicone oil.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Prolactin stimulation in multiple sclerosis--an indicator of disease subtypes and activity?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Prolactin Suppresses Glucocorticoid-Induced Thymocyte Apoptosis in Vivo

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501038

25 November 2018

Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

A pilot study of MRI activity before and during interferon beta-1a therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Prolactin secretion is increased in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Serum prolactin levels in active multiple sclerosis and during cyclosporin treatment

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Prolactin and autoimmunity

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Effect of elevated serum prolactin concentrations on the immunophenotype of human lymphocytes, mitogen-induced proliferation and phagocytic activity of polymorphonuclear cells

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-6-19

21 January 2018

Multihormonal response to dexamethasone. A study in atopic dermatitis and normal controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/16719908

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2377-6-19

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2377-6-19

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30816299&oldid=2194992328"